Audiovestibular clinician experiences and opinions about cisplatin vestibulotoxicity
Prayuenyong, Pattarawadee; Kasbekar, Anand V.; Hall, Deborah A.; Baguley, David M.
Anand V. Kasbekar
Deborah A. Hall
David M. Baguley
Vestibulotoxicity associated with cisplatin chemotherapy is known to exist, but the extent, severity, and impact is unclear from the literature. This study explored knowledge, experiences, and opinions of audiovestibular professionals about cisplatin vestibulotoxicity.
An online survey was disseminated to clinicians working in the audiovestibular field.
Ninety-three respondents participated in the survey. Most professionals were aware of potential vestibulotoxicity associated with cisplatin chemotherapy. Thirty-three percent of the respondents reported that they had seen patients with cisplatin vestibulotoxicity. Forty percent of them were confident in making the diagnosis and in managing the patient in this situation. The prevalence and impact of vestibulotoxicity including practicality of the assessment should be considered when designing an effective vestibulotoxicity screening protocol.
This study provides a better understanding of cisplatin vestibulotoxicity from the perspectives of audiovestibular clinicians, which will underpin appropriate detection and management of the condition.
|Journal Article Type||Article|
|Journal||European Archives of Oto-Rhino-Laryngology|
|Peer Reviewed||Peer Reviewed|
|APA6 Citation||Prayuenyong, P., Kasbekar, A. V., Hall, D. A., & Baguley, D. M. (2020). Audiovestibular clinician experiences and opinions about cisplatin vestibulotoxicity. European Archives of Oto-Rhino-Laryngology, https://doi.org/10.1007/s00405-020-06033-4|
|Keywords||Otorhinolaryngology; General Medicine|
|Additional Information||Received: 10 January 2020; Accepted: 1 May 2020; First Online: 19 May 2020; : ; : The authors declare that they have no conflict of interest.; : All procedures performed in studies involving human participants were in accordance with the ethical standards of the national research committee (East Midlands—Nottingham Research Ethics Committee; Reference number 18/EM/0369) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.; : Informed consent was obtained from all individual participants included in the study.|
You might also like
Exploring tinnitus heterogeneity
A process for prioritising systematic reviews in tinnitus
Readability assessment of self-report hyperacusis questionnaires
Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy